ReviewEndocrine2025
Intricate diagnosis due to falsely elevated testosterone levels by immunoassay.
Review in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Apparent Hyperandrogenemia Due to Immunoassay Interference Resolved by Liquid Chromatography-Tandem Mass Spectrometry.JCEM case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHormone immunoassay may be subject to interferences and, although rarely reported, this can occur for testosterone too. This work is aimed to highlight the importance of considering possible analytical interferences when the biochemical data doesn't match with the clinical picture.
methodsWe report three cases of insidious diagnosis due to laboratory interference in testosterone immunoassay, and we provide a brief literature review on this issue.
resultsWe found falsely high testosterone levels due to the presence of heterophilic antibodies, leading to unnecessary investigations, misdiagnosis and inappropriate treatments.
conclusionThe detection of elevated testosterone levels on immunoassay not corresponding to clinical findings need to be confirmed by liquid chromatography-tandem mass spectroscopy, prior to escalation of complex diagnostic investigation and care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.